21 – 30 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance : a population-based study
(
- Contribution to journal › Article
-
Mark
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
(
- Contribution to journal › Article
- 2018
-
Mark
Bortezomib-induced peripheral neuropathy : A genome-wide association study on multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma
(
- Contribution to journal › Article
-
Mark
Rapidly changing myeloma epidemiology in the general population : Increased incidence, older patients, and longer survival
(
- Contribution to journal › Scientific review
-
Mark
Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
(
- Contribution to journal › Letter
-
Mark
Chemotherapy-induced peripheral neuropathy : Evidence from genome-wide association studies and replication within multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Identification and characterization of DNA sequence variants associated with multiple myeloma
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
(
- Contribution to journal › Article
- 2017
-
Mark
Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy : Replication of the Reported Candidate Susceptibility Loci
(
- Contribution to journal › Article